Managing Director @ Tianshi Capital (January 2011 - Present)
Director @ Haoyisheng.com (January 2000 - Present)
Founder @ Lysigen, a subsidiary of Precisio Biotix Therapeutics (February 2020 - Present)
Former Founder and Chairman @ Tiger Medical Group (January 2005 - January 2013)
Former Founder and Chairman @ Excel PharmaStudies (January 2000 - January 2009)
Mark Engel Education
Notre Dame
Mark Engel Skills
Biotechnology
Business Development
Business Strategy
Clinical Trials
Commercialization
Cross-functional Team Leadership
Entrepreneurship
FDA
Healthcare
Life Sciences
Lifesciences
Medical Devices
Mergers & Acquisitions
Pharmaceutical Industry
Process Improvement
Product Development
Start-ups
Strategic Planning
Team Building
Marketing Strategy
Mergers and Acquisitions
Cross Functional Team Leadership
Project Management
Marketing
Microsoft Office
Startups
Start Ups
Program Management
Mark Engel Summary
Mark Engel, based in United States, is currently a Chairman and CEO at Precisio Biotix Therapeutics. Mark Engel brings experience from previous roles at Phagelux AgriHealth, Tianshi Capital, Haoyisheng.com and Lysigen, a subsidiary of Precisio Biotix Therapeutics. Mark Engel holds a Notre Dame. With a robust skill set that includes Biotechnology, Business Development, Business Strategy, Clinical Trials, Commercialization and more. Mark Engel has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Engel?
Find contact details for 700 million professionals.